Intelligence Platform

Patents

Browse 2,465 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

patent

US 6555582

Eye treatments using synthetic thyroid hormone compositions

The Regents of the University of California · Granted Tue Apr 29 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 24 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6552006

Immunomodulatory polynucleotides in treatment of an infection by an intracellular pathogen

The United States of America as represented by the Department of Veteran Affairs · Granted Tue Apr 22 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 17 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6545034

Use of etodolac for the treatment of chronic lymphocytic leukemia

The Regents of the University of California · Granted Tue Apr 08 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 03 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6537768

Diagnosis, prevention and treatment of ulcerative colitis, and clinical subtypes thereof,

The Regents of the University of California · Granted Tue Mar 25 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 20 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6534283

Method for treatment and prevention of physiological shock

The Regents of the University of California · Granted Tue Mar 18 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 13 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6531506

Inhibitors of epoxide hydrolases for the treatment of hypertension

The Regents of the University of California · Granted Tue Mar 11 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 06 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6525096

GABA and L-glutamic acid analogs for antiseizure treatment

Northwestern University · Granted Tue Feb 25 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 20 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6515003

Heterocyclic derivatives for the treatment of diabetes and other diseases

Maxim Pharmaceuticals, Inc. · Granted Tue Feb 04 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 30 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6511988

Activated iododerivatives for the treatment of cancer and aids

Isotechnika, Inc. · Granted Tue Jan 28 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 23 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6509492

Tannate compositions and methods of treatment

First Horizon Pharmaceutical Corporation · Granted Tue Jan 21 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 16 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6509319

EDTA and other chelators with or without antifungal antimicrobial agents for the preventio

The Board of Regents of the University of Texas System · Granted Tue Jan 21 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 16 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6503915

Composition and method for treatment of cerebral ischemia

The Board of Regents of the University of Texas System · Granted Tue Jan 07 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 02 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6503916

Treatment of ischemic brain injury

expired patent

US 6500834

Composition and method for treatment of cerebral ischemia

The Board of Regents of the University of Texas System · Granted Tue Dec 31 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 26 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6492426

Use of 1-aminoindan derivatives for treatment of mania in bipolar mood disorder

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Dec 10 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 05 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6489299

Methods for treatment of multiple sclerosis using peptide analogues at position 91 of huma

Neurocrine Biosciences, Inc. · Granted Tue Dec 03 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 28 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6489308

Inhibitors of serine protease activity, methods and compositions for treatment of nitric-o

The Regents of the University of Technology Office of Technology Transfer · Granted Tue Dec 03 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 28 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6486166

Suppression of cyclin kinase 2 activity for prevention and treatment of DNA viral infectio

The Board of Regents of the University of Texas · Granted Tue Nov 26 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 21 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6475724

Nucleic acids, kits, and methods for the diagnosis, prognosis and treatment of glaucoma an

The Regents of the University of California · Granted Tue Nov 05 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 31 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6470220

Diagnosis and treatment of cancers using in vivo magnetic domains

The Regents of the University of California · Granted Tue Oct 22 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 17 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6462067

Treatment and prevention of reactive oxygen metabolite-mediated cellular damage

Maxim Pharmaceuticals, Inc. · Granted Tue Oct 08 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 03 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6458590

Methods and compositions for treatment of restenosis

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Oct 01 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 26 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6455038

Reovirus for the treatment of cellular proliferative disorders

ONCOLYTICS BIOTECH INC. · Granted Tue Sep 24 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 19 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6433136

Cell density signal protein suitable for treatment of connective tissue injuries and defec

The Regents of the University of California · Granted Tue Aug 13 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 08 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired